Elucidating biological risk factors in suicide: Role of protein kinase A

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 35, Issue 4, 2011, Pages 831-841

  Dwivedi, Yogesh ^a   Pandey, Ghanshyam N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Animal models; Depression; G proteins; Human postmortem brain; Protein kinase A; Suicide

Indexed keywords

ADENYLATE CYCLASE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; CALCIUM ION; CLOZAPINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; GLUCOCORTICOID; GUANINE NUCLEOTIDE BINDING PROTEIN; HALOPERIDOL; MITOGEN ACTIVATED PROTEIN KINASE; NEUROLEPTIC AGENT; RAP1 PROTEIN;

CALCIUM TRANSPORT; CORPUS STRIATUM; DEPRESSION; GENE EXPRESSION REGULATION; HELPLESSNESS; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; NERVE CELL PLASTICITY; NONHUMAN; PREFRONTAL CORTEX; PROTEIN PHOSPHORYLATION; RISK FACTOR; SCHIZOPHRENIA; SHORT SURVEY; SIGNAL TRANSDUCTION; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT;

ADENYLATE CYCLASE; ANTIPSYCHOTIC AGENTS; BIOLOGICAL MARKERS; BRAIN; BRAIN CHEMISTRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GLUCOCORTICOIDS; GTP-BINDING PROTEINS; HELPLESSNESS, LEARNED; HUMANS; RAP1 GTP-BINDING PROTEINS; RISK FACTORS; SIGNAL TRANSDUCTION; STRESS, PSYCHOLOGICAL; SUICIDE;

EID: 79956044874     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2010.08.025     Document Type: Short Survey

References (160)

1. Abel T., Nguyen P.V. Regulation of hippocampus-dependent memory by cyclic AMP-dependent protein kinase. Prog Brain Res 2008, 169:97-115.
2. Adams J.A., McGlone M.L., Gibson R., Taylor S.S. Phosphorylation modulates catalytic function and regulation in the cAMP-dependent protein kinase. Biochemistry 1995, 34:2447-2454.
3. Aganova E.A., Uranova N.A. Morphometric analysis of synaptic contacts in the anterior limbic cortex in the endogenous psychoses. Neurosci Behav Physiol 1992, 22:59-65.
4. Altamura A.C., Bassetti R., Bignotti S., Pioli R., Mundo E. Clinical variables related to suicide attempts in schizophrenic patients: a retrospective study. Schizophr Res 2003, 60:47-55.
5. Altar C.A., Cai N., Bliven T., Juhasz M., Conner J.M., Acheson A.L., et al. Anterograde transport of brain-derived neurotrophic factor and its role in the brain. Nature 1997, 389:856-860.
6. Altshuler L.L., Casanova M.F., Goldberg T.E., Kleinman J.E. The hippocampus and parahippocampus in schizophrenia, suicide, and control brains. Arch Gen Psychiatry 1990, 47:1029-1034.
7. Arato M., Banki C.M., Bissette G., Nemeroff C.B. Elevated CSF CRF in suicide victims. Biol Psychiatry 1989, 25:355-359.
8. Avissar S., Nechamkin Y., Roitman G., Schreiber G. Reduced G protein functions and immunoreactive levels in mononuclear leukocytes of patients with depression. Am J Psychiatry 1997, 154:211-217.
9. Bartrup J.T., Moorman J.M., Newberry N.R. BDNF enhances neuronal growth and synaptic activity in hippocampal cell cultures. NeuroReport 1997, 8:3791-3794.
10. Beebe S.J. The cAMP-dependent protein kinases and cAMP signal transduction. Semin Cancer Biol 1994, 5:285-294.
11. Bertolote J.M. Suicide in the world: an epidemiological overview, 1959-2000. Suicide: an Unnecessary Death 2001, 3-10. Dunitz, London, England. D. Wasserman (Ed.).
12. Bornfeldt K.E., Krebs E.G. Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle. Cell Signal 1999, 11:465-477.
13. Borrelli E., Montmayeur J.P., Foulkes N.S., Sassone-Corsi P. Signal transduction and gene control: the cAMP pathway. Crit Rev Oncog 1992, 3:321-338.
14. Bos J.L., de Rooij J., Reedquist K.A. Rap1 signaling adhering to new models. Mol Cell Biol 2001, 2:369-377.
15. Brandon E.P., Logue S.F., Adams M.R., et al. Defective motor behavior and neural gene expression in RIIβ-protein kinase A mutant mice. J Neurosci 1998, 18:3639-3649.
16. Bremner J.D., Narayan M., Anderson E.R., Staib L.H., Miller H.L., Charney D.S. Hippocampal volume reduction in major depression. Am J Psychiatry 2000, 157:115-118.
17. Brent D., Kolko D., Wartella M., et al. Adolescent psychiatric inpatients' risk of suicide attempt at 6-month follow-up. J Am Acad Child Adolesc Psychiatry 1993, 32:95-105.
18. Brent D., Bridge J., Johnson B., Connolly J. Suicidal behavior runs in families: a controlled family study of adolescent suicide victims. Arch Gen Psychiatry 1996, 53:1145-1149.
19. Bugrim A.E. Regulation of Ca2+ release by cAMP-dependent protein kinase: a mechanism for agonist-specific calcium signalingβ. Cell Calcium 1999, 25:219-226.
20. Cadd G.G., Uhler M.D., McKnight G.S. Holoenzymes of cAMP-dependent protein kinase containing the neural form of type I regulatory subunit have an increased sensitivity to cyclic nucleotides. J Biol Chem 1990, 265:19502-19506.
21. Cauthron R.D., Carter K.B., Liauw S., Steinberg R.A. Physiological phosphorylation of protein kinase A at Thr-197 is by a protein kinase A kinase. Mol Cell Biol 1998, 18:1416-1423.
22. Cheng X., Ma Y., Moore M., Hemmings B.A., Taylor S.S. Phosphorylation and activation of cAMP dependent protein kinase by phosphoinositide-dependent protein kinase. Proc Natl Acad Sci USA 1998, 95:9849-9854.
23. Cheung E.C., Slack R.S. Emerging role for ERK as a key regulator of neuronal apoptosis. Sci STKE 2004, 251:PE45.
24. Clapham D.E., Neer E.J. G protein beta gamma subunits. Annu Rev Pharmacol Toxicol 1997, 37:167-203.
25. Clayton P.J. Suicide. Psychiatr Clin North Am 1985, 8:203-214.
26. Clegg C.H., McKnight G.S. Genetic characterization of a brain-specific form of the type I regulatory subunit of cAMP-dependent protein kinase. Proc Natl Acad Sci USA 1988, 85:3703-3707.
27. Constantinescu A., Gordon A.S., Diamond I. cAMP-dependent protein kinase types I and II differentially regulate cAMP response element-mediated gene expression. J Biol Chem 2002, 277:18810-18816.
28. Cotter D., Mackay D., Chana G., Beasley C., Landau S., Everall I.P. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex 2002, 12:386-394.
29. Cowburn R.F., Marcusson J.O., Eriksson A., Wiehager B., O'Neill C. Adenylyl cyclase activity and G-protein subunit levels in postmortem frontal cortex of suicide victims. Brain Res 1994, 633:297-304.
30. Dawood T., Anderson J., Barton D., Lambert E., Esler M., Hotchkin E. Reduced overflow of BDNF from the brain is linked with suicide risk in depressive illness. Mol Psychiatry 2007, 12:981-983.
31. Deveci A., Aydemir O., Taskin O., Taneli F., Esen-Danaci A. Serum BDNF levels in suicide attempters related to psychosocial stressors: a comparative study with depression. Neuropsychobiology 2007, 56:93-97.
32. Dowlatshahi D., MacQueen G.M., Wang J.F., Young L.T. Increased temporal cortex CREB concentrations and antidepression treatment in major depression. Lancet 1998, 352:1754-1755.
33. Dugan L.L., Kim J.S., Zhang Y., Bart R.D., Sun Y., Holtzman D.M., et al. Differential effects of cAMP in neurons and astrocytes. J Biol Psychiatry 1999, 274:25842-25848.
34. Duman R.S., Monteggia L.M. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006, 59:1116-1127.
35. Duman R.S., Malberg J., Nakagawa S., D'Sa C. Neuronal plasticity and survival in mood disorders. Biol Psychiatry 2000, 48:732-739.
36. Dwivedi Y. The concept of dysregulated signal transduction and gene expression in the pathophysiology of mood disorders. Curr Psychiatry Rev 2005, 1:227-254.
37. Dwivedi Y. The concept of dysregulated signal transduction and gene expression in the pathophysiology of mood disorders. Curr Psychiatry Rev 2006, 1:227-257.
38. Dwivedi Y. BDNF in suicide pathogenesis. Ann Med 2010, 42:87-96.
39. Dwivedi Y., Pandey G.N. Adrenal glucocorticoids modulate [3H]cyclic AMP binding to protein kinase A (PKA), cyclic AMP-dependent PKA activity, and protein levels of selective regulatory and catalytic subunit isoforms of PKA in rat brain. J Pharmacol Exp Ther 2000, 294:103-116.
40. Dwivedi Y., Rizavi H.S., Roberts R.C., Conley R.C., Tamminga C.A., Pandey G.N. Reduced activation and expression of ERK1/2 MAP kinase in the post-mortem brain of depressed suicide subjects. J Neurochem 2001, 77:916-928.
41. Dwivedi Y., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. [3H]cAMP binding sites and protein kinase A activity in the prefrontal cortex of suicide victims. Am J Psychiatry 2002, 159:66-73.
42. Dwivedi Y., Rizavi H.S., Pandey G.N. Differential effects of haloperidol and clozapine on [(3)H]cAMP binding, protein kinase A (PKA) activity, and mRNA and protein expression of selective regulatory and catalytic subunit isoforms of PKA in rat brain. J Pharmacol Exp Ther 2002, 301:197-209.
43. Dwivedi Y., Rao J.S., Rizavi H.S., et al. Abnormal expression and functional characteristics of cyclic adenosine monophosphate response element-binding protein in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003, 60:273-282.
44. Dwivedi Y., Rizavi H.S., Conley R.R., Roberts R.C., Tamminga C.A., Pandey G.N. Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003, 60:804-815.
45. Dwivedi Y., Rizavi H.S., Shukla P.K., Lyons J., Faludi G., Palkovits M., et al. Protein kinase A in postmortem brain of depressed suicide victims: altered expression of specific regulatory and catalytic subunits. Biol Psychiatry 2004, 55:234-243.
46. Dwivedi Y., Mondal A.C., Rizavi H.S., Conley R.R. Suicide brain is associated with decreased expression of neurotrophins. Biol Psychiatry 2005, 58:315-324.
47. Dwivedi Y., Rizavi H.S., Conley R.R., Pandey G.N. ERK MAP kinase signaling in post-mortem brain of suicide subjects: differential regulation of upstream Raf kinases Raf-1 and B-Raf. Mol Psychiatry 2006, 11:86-98.
48. Dwivedi Y., Rizavi H., Zhang H., Mondal A., Roberts R.C., Conley R.R., et al. Neurotrophin receptor activation and expression in human postmortem brain: effect of suicide. Biol Psychiatry 2009, 65:319-328.
49. Fenton W.S., McGlashan T.H., Victor B.J., Blyler C.R. Symptoms, subtype, and suicidality in patients with schizophrenia spectrum disorders. Am J Psychiatry 1997, 154:199-204.
50. Francis S.H., Corbin J.D. Cyclic nucleotide-dependent protein kinases: intracellular receptors for cAMP and cGMP action. Crit Rev Clin Lab Sci 1999, 36:275-328.
51. Freissmuth M., Waldhoer M., Bofill-Cardoba E., Nanoff C. G protein antagonists. Trends Pharmacol Sci 1999, 20:237-245.
52. Gamm D.M., Baude E.J., Uhler M.D. The major catalytic subunit isoforms of cAMP-dependent protein kinase have distinct biochemical properties in vitro and in vivo. J Biol Chem 1996, 271:15736-15742.
53. Garcia R. Stress, synaptic plasticity, and psychopathology. Rev Neurosci 2002, 13:195-208.
54. Gilman A.G. G proteins: transducers of receptor-generated signals. Annu Rev Biochem 1987, 56:615-649.
55. Glick I.D., Zaninelli R., Hsu C., Young F.K., Weiss L., Gunay I., et al. Patterns of concomitant psychotropic medication use during a 2-year study comparing clozapine and olanzapine for the prevention of suicidal behavior. J Clin Psychiatry 2004, 65:679-685.
56. Committee on Pathophysiology and Prevention of Adolescent and Adult Suicide, Board on Neuroscience and Behavioral Health, Institute of Medicine of the National Academies. Reducing Suicide, A National Imperative 2002, National Academies Press, Washington, DC. S.K. Goldsmith, T.C. Pellmar, A.M. Kleinman, W.E. Bunney (Eds.).
57. Grewal S.S., Fass D.M., Yao H., Ellig C.L., Goodman R.H., Stork P.J. Calcium and cAMP signals differentially regulate cAMP-responsive element-binding protein function via a Rap1-extracellular signal-regulated kinase pathway. J Biol Chem 2000, 275:34433-34441.
58. Groves J.O. Is it time to reassess the BDNF hypothesis of depression?. Mol Psychiatry 2007, 12:1079-1088.
59. Hajsza T., MacLusky N.J., Leranth C. Short-term treatment with the antidepressant fluoxetine triggers pyramidal dendritic spine synapse formation in rat hippocampus. Eur J Neurosci 2005, 21:1299-1303.
60. Hamm H.E. The many faces of G protein signaling. J Biol Chem 1998, 273:669-672.
61. Hata Y., Kaibuchi K., Kawamura S., Hiroyoshi M., Shirataki H., Takai Y. Enhancement of the actions of smg p21 GDP/GTP exchange protein by the protein kinase A-catalyzed phosphorylation of smg p21. J Biol Chem 1991, 266:6571-6577.
62. Hattori M., Minato N. Rap1 GTPase: functions, regulation, and malignancy. J Biochem 2003, 134:479-484.
63. Hennen J., Baldessarini R.J. Suicidal risk during treatment with clozapine: a meta-analysis. Schizophr Res 2005, 73:139-145.
64. Hildebrandt J.D. Role of subunit diversity in signaling by heterotrimeric G proteins. Biochem Pharmacol 1997, 54:325-339.
65. Hiroi N., Wong M.L., Licinio J. Expression of corticotropin releasing hormone receptors type I and type II mRNA in suicide victims and controls. Mol Psychiatry 2001, 6:540-546.
66. Honer W.G. Assessing the machinery of mind: synapses in neuropsychiatric disorders. J Psychiatry Neurosci 1999, 24:116-121.
67. Huang E., Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 2001, 24:677-736.
68. Impey S., Obrietan K., Wong S.T., Poser S., Yano S., Wayman G., et al. Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron 1998, 21:869-883.
69. Joëls M., Karst H., Alfarez D., Heine V.M., Qin Y., van Riel E., et al. Effects of chronic stress on structure and cell function in rat hippocampus and hypothalamus. Stress 2004, 7:221-231.
70. Johns C.A., Stanley M., Stanley R. Suicide in schizophrenia. Ann NY Acad Sci 1986, 487:294-300.
71. Jordan J.D., Landau E.M., Iyengar R. Signaling networks: the origins of cellular multitasking. Cell 2000, 103:193-200.
72. Karege F., Bovier P., Stepanian R., Malafosse A. The effect of clinical outcome on platelet G proteins of major depressed patients. Eur Neuropsychopharmacol 1998, 8:89-94.
73. Karege F., Schwald M., Cisse M. Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neurosci Lett 2002, 328:261-264.
74. Karege F., Vaudan G., Schwald M., Perroud N., La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. Brain Res Mol Brain Res 2005, 136:29-37.
75. Kawata M., Matsui Y., Kondo J., Hishida T., Teranishi Y., Takai Y. A novel small molecular weight GTP-binding protein with the same putative effector domain as the ras proteins in bovine brain membranes: purification, determination of primary structure, and characterization. J Biol Chem 1988, 263:18965-18971.
76. Keck P.E., Strakowski S.M., McElroy S.L. The efficacy of atypical antipsychotics in the treatment of depressive symptoms, hostility, and suicidality in patients with schizophrenia. J Clin Psychiatry 2000, 61(Suppl 3):4-9.
77. Montout C., Casadebaig F., Lagnaoui R., et al. Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients. Schizophr Res 2002, 57:147-156.
78. Khan A., Khan S.R., Leventhal R.M., Brown W.A. Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the Food and Drug Administration database. Am J Psychiatry 2001, 158:1449-1454.
79. Kim Y.K., Lee H.P., Won S.D., Park E.Y., Lee H.Y., Lee B.H. Low plasma BDNF is associated with suicidal behavior in depression. Prog Neuropsychopharmacol Biol Psychiatry 2007, 31:578-579.
80. Kolkova K., Novitskaya V., Pedersen N., Berzin V., Bock E. Neural cell adhesion molecule-stimulated neurite outgrowth depends on activation of protein kinase C and the Ras-mitogen-activated protein kinase pathway. J Neurosci 2000, 20:2238-2246.
81. Lara J., Kusano K., House S., Gainer H. Interactions of cyclic adenosine monophosphate, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor treatment on the survival and growth of postnatal mesencephalic dopamine neurons in vitro. Exp Neurol 2003, 180:32-45.
82. Lee B.H., Kim Y.K. Reduced platelet BDNF level in patients with depression. Prog Neuropsychopharmacol Biol Psychiatry 2009, 33:849-853.
83. Lee B.H., Kim H., Park S.H., Kim Y.K. Decreased plasma BDNF level in depressive patients. J Affect Disord 2007, 101:239-244.
84. Liu M., Simon M.I. Regulation by cAMP-dependent protein kinase of a G-protein-mediated phospholipase C. Nature 1996, 382:83-87.
85. Lopez J.F., Palkovits M., Arato M., Mansour A., Akil H., Watson S.J. Localization and quantification of pro-opiomelanocortin mRNA and glucocorticoid receptor mRNA in pituitaries of suicide victims. Neuroendocrinology 1992, 56:491-501.
86. Lowther S., Katona C.L., Crompton M.R., Horton R.W. Brain [3H]cAMP binding sites are unaltered in depressed suicides, but decreased by antidepressants. Brain Res 1997, 758:223-228.
87. Ludvig N., Ribak C.E., Scott J.D., Rubin C.S. Immunocytochemical localization of the neural-specific regulatory subunit of the type II cyclic AMP-dependent protein kinase to postsynaptic structures in the rat brain. Brain Res 1990, 520:90-102.
88. Marshall R., Dragunow M. Is CREB a key to neuronal survival?. Trends Neurosci 2000, 23:48-53.
89. Matsushita M., Nairn A.C. Inhibition of the Ca2+/calmodulin-dependent protein kinase I cascade by cAMP-dependent protein kinase. J Biol Chem 1999, 274:10086-10093.
90. McEwen B.S. Stress and hippocampal plasticity. Annu Rev Neurosci 1999, 22:105-122.
91. McEwen B.S. Effects of adverse experiences for brain structure and function. Biol Psychiatry 2000, 48:713-714.
92. Meltzer H.Y. Decreasing suicide in schizophrenia. Psychiatr Times 2001, 18:1-5.
93. Meltzer H.Y., Okayli G. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Am J Psychiatry 1995, 152:183-190.
94. Meltzer H.Y., Alphs L., Green A.I., Altamura A.C., Anand R., Bertoldi A., et al. International Suicide Prevention Trial Study Group. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 2003, 60:82-91.
95. Minino A.M., Smith B.L. Deaths: preliminary data for 2000. Natl Vital Stat Rep 2002, 49:1-40.
96. Monk M. Epidemiology of suicide. Epidemiol Rev 1987, 9:51-69.
97. Morozov A., Muzzio I.A., Bourtcholadze R., Van-Strien N., Lapidus K., Yin D.Q. Rap1 couples cAMP signaling to a distinct pool of p42/44 MAPK regulating excitability, synaptic plasticity, learning, and memory. Cell 2003, 39:309-325.
98. National Center for Health Statistics Advance report of final mortality statistics. NCHS Monthly Vital Stat Rep 1992, 40.
99. Neer E.J. Heterotrimeric G proteins: organizers of transmembrane signals. Cell 1995, 80:249-257.
100. Nestler E.J., Greengard P. Protein phosphorylation and the regulation of neuronal function. Basic Neurochemistry: Molecular, Cellular, and Medical Aspects 1994, 449-474. Little Brown Press, Boston, MA. G.J. Siegel, R.W. Albers, B.W. Agranoff, P. Molinoff (Eds.).
101. Nestler E.J., Barrot M., DiLeone R.J., Eisch A.J., Gold S.J., Monteggia L.M. Neurobiology of depression. Neuron 2002, 34:13-25.
102. Neves S.R., Ram P.T., Iyengar R. G protein pathways. Science 2002, 296:1636-1639.
103. Nibuya M., Nestler E.J., Duman R.S. Chronic antidepressant administration increases the expression of cAMP response element-binding protein (CREB) in rat hippocampus. J Neurosci 1996, 16:2365-2372.
104. Odagaki Y., Garcia-Sevilla J.A., Huguelet P., La Harpe R., Koyama T., Guimon J. Cyclic AMP-mediated signaling components are upregulated in the prefrontal cortex of depressed suicide victims. Brain Res 2001, 898:224-231.
105. Ozawa H., Gsell W., Frolich L., et al. Imbalance of the Gs and Gi/o function in postmortem human brain of depressed patients. J Neural Transm Gen Sect 1993, 94:63-69.
106. Pacheco M.A., Stockmeier C., Meltzer H.Y., Overholser J.C., Dilley G.E., Jope R.S. Alterations in phosphoinositide signaling and G-protein levels in depressed suicide brain. Brain Res 1996, 723:37-45.
107. Pandey G.N., Dwivedi Y. Monoamine receptors and signal transduction mechanisms in suicide. Curr Psychiatry Rev 2006, 2:51-75.
108. Pandey G.N., Dwivedi Y. Noradrenergic function in suicide. Arch Suicide Res 2007, 11:235-246.
109. Pandey G.N., Dwivedi Y., Ren X., et al. Brain region specific alterations in the protein and mRNA levels of protein kinase A subunits in the postmortem brain of teenage suicide victims. Neuropsychopharmacology 2005, 30:1548-1556.
110. Pandey G.N., Dwivedi Y., Ren X., Rizavi H.S., Roberts R.C., Conley R.R. Cyclic AMP response element-binding protein in postmortem brain of teenage suicide victims: specific decrease in the prefrontal cortex but not the hippocampus. Int J Neuropsychopharmacol 2006, 18:1-9.
111. Perez J., Tardito D., Mori S., Racagni G., Smeraldi E., Zanardi R. Abnormalities of cyclic adenosine monophosphate signaling in platelets from untreated patients with bipolar disorder. Arch Gen Psychiatry 1999, 56:248-253.
112. Perez J., Tardito D., Mori S., Racagni G., Smeraldi E., Zanardi R. Altered Rap1 endogenous phosphorylation and levels in platelets from patients with bipolar disorder. J Psychiatr Res 2000, 34:99-104.
113. Perez J., Tardito D., Mori S., Racagni G., Smeraldi E., Zanardi R. Protein kinase A and Rap1 levels in platelets of untreated patients with major depression. Mol Psychiatry 2001, 6:44-49.
114. Perez J., Tardito D., Racagni G., Smeraldi E., Zanardi R. cAMP signaling pathway in depressed patients with psychotic features. Mol Psychiatry 2002, 7:208-212.
115. Petty F., Sherman A.D. Reversal of learned helplessness by imipramine. Commun Psychopharmacol 1979, 3:371-373.
116. Pinikahana J., Happell B., Keks N.A. Suicide and schizophrenia: a review of literature for the decade (1990-1999) and implications for mental health nursing. Issues Ment Health Nurs 2003, 24:27-43.
117. Pizon V., Lerosey I., Chardin P., Tavitian A. Nucleotide sequence of a human cDNA encoding a ras-related protein (rap1B). Nucleic Acids Res 1988, 16:7719.
118. Qi M., Zhuo M., Skalhegg B.S., et al. Impaired hippocampal plasticity in mice lacking the Cβ catalytic subunit of cAMP-dependent protein kinase. Proc Natl Acad Sci USA 1996, 93:1571-1576.
119. Qiu W., Zhuang S., von Lintig F.C., Boss G.R., Pilz R.B. Cell type-specific regulation of B-Raf kinase by cAMP and 14-3-3 proteins. J Biol Chem 2000, 275:31921-31929.
120. Quilliam L.A., Mueller H., Bohl B.P., Prossnitz V., Sklar L.A., Der C.J., et al. Rap1A is a substrate for cyclic AMP-dependent protein kinase in human. J Immunol 1991, 147:1628-1635.
121. Radomsky E.D., Haas G.L., Mann J.J., Sweeney J.A. Suicidal behavior in patients with schizophrenia and other psychotic disorders. Am J Psychiatry 1999, 156:1590-1595.
122. Rajkowska G. Morphometric methods for studying the prefrontal cortex in suicide victims and psychiatric patients. Ann NY Acad Sci U S A 1997, 836:253-268.
123. Rajkowska G. Cell pathology in mood disorders. Semin Clin Neuropsychiatry 2002, 7:281-292.
124. Rosoklija G., Toomayan G., Ellis S.P., Keilp J., Mann J.J., Latov N. Structural abnormalities of subicular dendrites in subjects with schizophrenia and mood disorders: preliminary findings. Arch Gen Psychiatry 2000, 57:349-356.
125. Sackeim H.A. Functional brain circuits in depression and remission. Arch Gen Psychiatry 2001, 58:649-650.
126. Sarkar D., Erlichman J., Rubin C.S. Identification of a calmodulin-binding protein that co-purifies with the regulatory subunit of brain protein kinase II. J Biol Chem 1984, 259:9840-9846.
127. Scott J.D., Glaccum M.B., Zoller M.J., Uhler M.D., Helfman D.M., McKnight G.S., et al. The molecular cloning of a type II regulatory subunit of the cAMP-dependent protein kinase from rat skeletal muscle and mouse brain. Proc Natl Acad Sci USA 1987, 84:5192-5196.
128. Scott J.D., Stofko R.E., McDonald J.R., Comer J.D., Vitalis E.A., Mangili J.A. Type II regulatory subunit dimerization determines the subcellular localization of the cAMP-dependent protein kinase. J Biol Chem 1990, 265:21561-21566.
129. Seligman M.E., Maier S.F. Failure to escape traumatic shock. J Exp Psychol 1967, 74:1-9.
130. Sengupta N., Vinod P.K., Venkatesh K.V. Crosstalk between cAMP-PKA and MAP kinase pathways is a key regulatory design necessary to regulate FLO11 expression. Biophys Chem 2007, 125:59-71.
131. Sheline Y.I. 3D MRI studies of neuroanatomic changes in unipolar depression: the role of stress and medical comorbidity. Biol Psychiatry 2000, 48:791-800.
132. Shelton R.C., Hal Manier D., Lewis D.A. Protein kinases A and C in post-mortem prefrontal cortex from persons with major depression and normal controls. Int J Neuropsychopharmacol 2009, 12:1223-1232.
133. Shelton R.C., Sanders-Bush E., Manier D.H., Lewis D.A. Elevated 5-HT 2A receptors in postmortem prefrontal cortex in major depression is associated with reduced activity of protein kinase A. Neuroscience 2009, 158:1406-1415.
134. Sherman A.D., Sacquitne J.L., Petty F. Specificity of the learned helplessness model of depression. Pharmacol Biochem Behav 1982, 16:449-454.
135. Simon M.I., Strathmann M.P., Gautam N. Diversity of G proteins in signal transduction. Science 1991, 252:802-808.
136. Siris S.G. Suicide and schizophrenia. J Psychopharmacol 2001, 15:127-135.
137. Skalhegg B.S., Tasken K. Specificity in the cAMP/PKA signaling pathway: differential expression, regulation, and subcellular localization of subunits of PKA. Front Biosci 2000, 5:D678-D693.
138. Spaulding S.W. The ways in which hormones change cyclic adenosine 3'5'-monophosphate-dependent protein kinase subunits, and how such changes affect cell behavior. Endocr Rev 1993, 14:632-650.
139. Spleiss O., van Calker D., Scharer L., Adamovic K., Berger M., Gebicke-Haerter P.J. Abnormal G protein alpha(s)- and alpha (i2)-subunit mRNA expression in bipolar affective disorder. Mol Psychiatry 1998, 3:512-520.
140. Steinberg R.A., Cauthron R.D., Symcox M.M., Shuntoh H. Autoactivation of catalytic (C alpha) subunit of cyclic AMP-dependent protein kinase by phosphorylation of threonine 197. Mol Cell Biol 1993, 13:2332-2341.
141. Stockmeier C.A. Neurobiology of serotonin in depression and suicide. Ann NY Acad Sci 1997, 836:220-232.
142. Sweatt J.D. Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol 2004, 14:311-317.
143. Thiele T.E., Willis B., Stadler J., Reynolds J.G., Bernstein I.L., McKnight G.S. High ethanol consumption and low sensitivity to ethanol-induced sedation in protein kinase A-mutant mice. J Neurosci 2000, 20:RC75.
144. Thoenen H. Neurotrophins and neuronal plasticity. Science 1995, 270:593-598.
145. Uhler M.D., Chrivia J.C., McKnight G.S. Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase. J Biol Chem 1986, 261:15360-15363.
146. Van Heeringen K., Audenaert K., Van de Wiele L., Verstraete A. Cortisol in violent suicide attempters: association with monoamines and personality. J Affect Disord 2000, 60:181-189.
147. Villalba M., Bockaert J., Journot L. Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar granule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J Neurosci 1997, 17:83-90.
148. Vossler M.R., Yao H., York R.D., Pan M.G., Rim C.S., Stork P.J. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 1997, 89:73-82.
149. Wagstaff A., Perry C. Clozapine: in prevention of suicide in patients with schizophrenia or schizoaffective disorder. CNS Drugs 2003, 17:273-280.
150. Walker A.M., Lanza L.L., Arellano F., Rothman K.J. Mortality in current and former users of clozapine. Epidemiology 1997, 8:671-677.
151. Walsh D.A., Perkins J.P., Krebs E.G. An adenosine 3',5'-monophosphate-dependant protein kinase from rabbit skeletal muscle. J Biol Chem 1968, 243:3763-3765.
152. Wen Y., Anwer K., Singh S.P., Sanborn B.M. Protein kinase A inhibits phospholipase C activity and alters protein phosphorylation in rat myometrial plasma membranes. Endocrinology 1992, 131:1377-1382.
153. Winokur G., Tsuang M. The Iowa 500: suicide in mania, depression and schizophrenia. Am J Psychiatry 1975, 132:650-651.
154. Wolf S., Martinez C., Majzoub J.A. Inducible binding of cyclic adenosine 3',5'-monophosphate (cAMP)-responsive element binding protein (CREB) to a cAMP-responsive promoter in vivo. Mol Endocrinol 1999, 13:659-669.
155. Yamada S., Yamamoto M., Ozawa H., Piederer P., Saito T. Reduced phosphorylation of cyclic AMP responsive element-binding protein in the postmortem orbitofrontal cortex of patients with major depressive disorder. J Neural Transm 2003, 110:671-680.
156. Young L.T. Postreceptor pathways for signal transduction in depression and bipolar disorder. J Psychiatry Neurosci 2001, 26(suppl):S17-S22.
157. Young L.T., Li P.P., Kish S.J., et al. Cerebral cortex Gs alpha protein levels and forskolin-stimulated cyclic AMP formation are increased in bipolar affective disorder. J Neurochem 1993, 61:890-898.
158. Young L.T., Bezchlibnyk Y.B., Chen B., Wang J.-F., MacQueen G.M. Amygdala cyclic adenosine monophosphate response element-binding protein phosphorylation in patients with mood disorders: effects of diagnosis, suicide, and drug treatment. Biol Psychiatry 2004, 55:570-577.
159. Zubenko G.S., Hughes H.B., Maher B.S., Stiffler J.S., Zubenko W.N., Marazita M.L. Genetic linkage of region containing the CREB1 gene to depressive disorders in women from families with recurrent, early-onset, major depression. Am J Med Genet 2002, 114:980-987.
160. Zwartkruis F.J.T., Bos J.L. Ras and Rap1: two highly related small GTPases with distinct function. Exp Cell Res 1999, 253:157-165.